Registration Decision RD2020-12, Fluxapyroxad and Xzemplar
This decision is consistent with the Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar, whichcontains a detailed evaluation of the information submitted in support of this registration.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-29
Data overview
- Formats
- HTML
- File languages
- English, French